Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/21645515.2020.1794685 http://scihub22266oqcxt.onion/10.1080/21645515.2020.1794685 32845742!7484576!32845742     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Hum+Vaccin+Immunother 2020 ; 16 (12): 3034-3042 Nephropedia Template TP {{tp|p=32845742|t=2020. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2 |pdf=|usr=}}{{32845742}} gab.com Text Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2 JO: Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=32845742 #FOAvip The novel coronavirus disease (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has rapidly spread across the world. This resulted an alarming number of fatalities with millions of confirmed infected cases, pretending severe public health, economic, and social threats. There is no specific therapeutic drugs or licensed vaccines or treatments to fight against lethal COVID-19 infections. Given the significant threats of COVID-19, the global organizations are racing to identify epidemiological and pathogenic mechanisms of COVID-19 to find treatment regimens and effective therapeutic modalities for future prevention. Herein, we reviewed the therapeutic interventions and vaccines for COVID-19 based on the existing knowledge and understanding of similar coronaviruses, including MERS-CoV and SARS-CoV. The information constitutes a paramount intellectual basis to sustenance ongoing research for the discovery of vaccines and therapeutic agents. This review signifies the most available frontiers in the viral vaccine development approaches to counter the COVID-19/SARS-CoV-2. Twit Text FOAVip Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2 ????Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=32845742 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32845742 #FOAvip English Wikipedia <ref>{{Cite pmid|32845742}}</ref> Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2 #MMPMID32845742 Bilal M; Iqbal HMN Hum Vaccin Immunother 2020[Dec]; 16 (12): 3034-3042 PMID32845742show ga The novel coronavirus disease (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has rapidly spread across the world. This resulted an alarming number of fatalities with millions of confirmed infected cases, pretending severe public health, economic, and social threats. There is no specific therapeutic drugs or licensed vaccines or treatments to fight against lethal COVID-19 infections. Given the significant threats of COVID-19, the global organizations are racing to identify epidemiological and pathogenic mechanisms of COVID-19 to find treatment regimens and effective therapeutic modalities for future prevention. Herein, we reviewed the therapeutic interventions and vaccines for COVID-19 based on the existing knowledge and understanding of similar coronaviruses, including MERS-CoV and SARS-CoV. The information constitutes a paramount intellectual basis to sustenance ongoing research for the discovery of vaccines and therapeutic agents. This review signifies the most available frontiers in the viral vaccine development approaches to counter the COVID-19/SARS-CoV-2. |Animals[MESH] |Antibodies, Monoclonal/administration & dosage/immunology[MESH] |Antiviral Agents/*administration & dosage/immunology[MESH] |COVID-19 Vaccines/*administration & dosage/immunology[MESH] |COVID-19/epidemiology/immunology/*prevention & control[MESH] |Coronavirus Infections/epidemiology/immunology/*prevention & control[MESH] |Humans[MESH] |Protease Inhibitors/administration & dosage/immunology[MESH] |SARS-CoV-2/drug effects/immunology[MESH] |Severe Acute Respiratory Syndrome/epidemiology/immunology/*prevention & control[MESH]Recent advances in therapeutic modalities and vaccines to counter COV(epmc).pdf DeepDyve Pubget Overpricing